New S3 guidelines on atrial fibrillation
Experts discuss the new S3 guidelines on atrial fibrillation in a webinar.
Startseite
Aftermovie of the 10th AFNET EHRA Consensus Conference
From May 5–7, 2025, the 10th AFNET EHRA Consensus Conference took place in Gressy, France.
We captured the inspiring atmosphere and some voices of the participants, bringing them together in this aftermovie. A heartfelt thank you to everyone whose ideas and dedication made this event a true success!
MAESTRIA-AFNET 10: Investigator Meeting in Madrid
The entire MAESTRIA – AFNET 10 team is looking forward to welcoming study sites in Madrid on 30th of August.
AFNET Lecture Award – Vortrag Prof. John Camm – DGK Jahrestagung 2025
Prof Camm was honoured with the AFNET Lecture Award at the AFNET general meeting during the DGK 2025 annual conference in Mannheim. In this document you can see his lecture at the award ceremony.
MAESTRIA Consortium Meeting, Paris: 8th and 9th May 2025
The MAESTRIA Consortium, which consists of 18 partners from different European countries, met for the 3rd time on 8 and 9 May to discuss the progress of the EU-funded MAESTRIA project.
Impressions of the 10th AFNET EHRA Consensus Conference
From May 5 to 7, 2025, the 10th AFNET EHRA Consensus Conference took place in Gressy, France. Below are some impressions of the presentations, breakout sessions and the program around it
EAST-STROKE Videointerview
Prof. Dr. med. Götz Thomalla (UKE) and Dr. med. Märit Jensen (UKE) have recorded a video on the new EAST-STROKE trial in layman’s terms.
The EAST-STROKE (‘Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE’) trial is led by scientist from the University Medical Centre Hamburg-Eppendorf (UKE) and investigates whether early rhythm-control treatment can effectively and safely prevent strokes. The project is funded by the EU as part of ‘Horizon Europe’. AFNET is partner for dissemination and exploitation.
New treatment option for acute stroke in atrial fibrillation in a clinical trial
Patients with an acute stroke and atrial fibrillation have a particularly high risk of a recurrent stroke and other serious cardiovascular events. A Europe-wide clinical trial led by scientists from the University Medical Centre Hamburg-Eppendorf (UKE) is now investigating whether early rhythm-control treatment can effectively and safely prevent strokes.
Prof. Dr. med. Thomas Meinertz
On behalf of all our members, we would like to congratulate our AFNET founding member Prof Dr Meinertz on his 80th birthday! 🎈
We wish them all the best and good health for the coming years. Thank you very much for your great commitment and tireless dedication to AFNET!
Does early catheter ablation improve outcomes in patients with atrial fibrillation and comorbidities?
Many patients with atrial fibrillation (AF) experience stroke, cardiovascular death and other cardiovascular complications. Early rhythm control can prevent some of these events but is often withheld from elderly patients with multiple comorbidities. Catheter ablation is the most effective rhythm-controlling therapy but has mainly been tested in younger patients. The German Atrial Fibrillation Network (AFNET) initiated the EASThigh – AFNET 11 trial to investigate whether early catheter ablation can reduce outcomes in patients with AF and comorbidities. EASThigh – AFNET 11 enrolled the first patient on 14.10.2024.
Atrial fibrillation (AF) epidemic affects the health of a growing number of people worldwide. Patients with AF are at risk of stroke, heart failure, death and dementia. Many patients develop AF in old age, and older people with cardiovascular comorbidities are at highest risk of AF-related complications.